Securin identifies a subgroup of patients with poor outcome in rectal cancer treated with long-course (chemo)radiotherapy

S. Tuulia AvorantaDepartment of Oncology and Radiotherapy, University of Turku and Turku University Hospital, Hämeentie 11, FIN-20521, Turku, FinlandCorrespondence[email protected]

Eija A. KorkeilaDepartment of Oncology and Radiotherapy, University of Turku and Turku University Hospital, Hämeentie 11, FIN-20521, Turku, Finland

Heikki R. I. MinnDepartment of Oncology and Radiotherapy, University of Turku and Turku University Hospital, Hämeentie 11, FIN-20521, Turku, Finland;Turku PET Centre, PB 52, FIN-20521, Turku, Finland

Kari J. SyrjänenDepartment of Oncology and Radiotherapy, University of Turku and Turku University Hospital, Hämeentie 11, FIN-20521, Turku, Finland

Seppo O. PyrhönenDepartment of Oncology and Radiotherapy, University of Turku and Turku University Hospital, Hämeentie 11, FIN-20521, Turku, Finland

Jari T. T. SundströmDepartment of Pathology, University of Turku and Turku University Hospital, Kiinamyllynkatu 10, FIN-20520, Turku, Finland

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Bengt Glimelius. (2012) Multidisciplinary treatment of patients with rectal cancer: Development during the past decades and plans for the future. Upsala Journal of Medical Sciences 117:2, pages 225-236.
Read now

Articles from other publishers (3)

Liam Poynter, Dieter Galea, Kirill Veselkov, Alexander Mirnezami, James Kinross, Jeremy Nicholson, Zoltán Takáts, Ara Darzi & Reza Mirnezami. (2019) Network Mapping of Molecular Biomarkers Influencing Radiation Response in Rectal Cancer. Clinical Colorectal Cancer 18:2, pages e210-e222.
Crossref

Ilkka Heikkinen, Alhadi Almangush, Jaana Hagström, Ibrahim O. Bello, Joonas H. Kauppila, Laura K. Mäkinen, Caj Haglund, Pentti Nieminen, Tuula Salo & Ilmo Leivo. (2016) Does securin expression have significance in prognostication of oral tongue cancer? A pilot study. European Archives of Oto-Rhino-Laryngology 273:11, pages 3905-3911.
Crossref

Sheng-Yi Yu, Huei-Fang Liu, Su-Pei Wang, Chia-Ching Chang, Chuan-Mei Tsai & Jui-I Chao. (2013) Evidence of securin-mediated resistance to gefitinib-induced apoptosis in human cancer cells. Chemico-Biological Interactions 203:2, pages 412-422.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Securin identifies a subgroup of patients with poor outcome in rectal cancer treated with long-course (chemo)radiotherapy

Articles from other publishers (3)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Securin identifies a subgroup of patients with poor outcome in rectal cancer treated with long-course (chemo)radiotherapy

Citations (4)

Read on this site (1)

Articles from other publishers (3)

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date